<DOC>
	<DOCNO>NCT00817011</DOCNO>
	<brief_summary>The Purpose study predict antidepressant response advance use pharmacogenomics peripheral biological marker depress patient .</brief_summary>
	<brief_title>Development Pharmacogenomic Method Predict Antidepressant Responsiveness</brief_title>
	<detailed_description>The difficulty treat depressed patient 1 ) patient n't respond antidepressant 40 % , 2 ) The time lag exist patient respond antidepressant show treatment effect . If predict response antidepressant advance , would overcome problem . Drug response generally know related individual genetic information environmental factor . We go investigation antidepressant response use approach .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Trazodone</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<criteria>1 . 25 &lt; age &lt; 85 2. major depressed patient satisfied diagnosis criterion depression DSMIV 3. interview one patient 's family member objective diagnosis final diagnosis decision agreement two psychiatric physician 1. receive psychotropic medication within 2 week study fluoxetine within 4 week 2. potential study participant pregnancy , significant medical condition , abnormal laboratory baseline value , unstable psychiatric feature ( eg.suicidal ) , history alcohol drug dependence , seizure , head trauma loss consciousness , neurological illness , concomitant Axis I psychiatric disorder .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>depression</keyword>
	<keyword>pharmacogenomics</keyword>
	<keyword>antidepressant response</keyword>
	<keyword>biological marker</keyword>
	<keyword>clinical variable</keyword>
</DOC>